Expression of c-erbB3 protein in primary breast carcinomas
1998

c-erbB3 Protein Expression in Breast Cancer

Sample size: 104 publication Evidence: moderate

Author Information

Author(s): R Naidul, M Yadav, S Nair, MK Kutty

Primary Institution: University of Malaya

Hypothesis

The study investigates the expression of c-erbB3 protein in primary breast carcinomas and its association with clinical parameters.

Conclusion

Overexpression of c-erbB3 protein is significantly associated with poorly differentiated breast tumors and may serve as a marker for poor prognosis.

Supporting Evidence

  • 67% of comedo DCIS cases showed overexpression of c-erbB3.
  • 52% of invasive ductal carcinomas exhibited strong c-erbB3 positivity.
  • 71% of poorly differentiated tumors were strongly positive for c-erbB3.
  • High percentages of oestrogen receptor-negative (59%) and lymph node-positive (63%) tumors were c-erbB3 positive.

Takeaway

This study looked at a protein called c-erbB3 in breast cancer samples and found that many tumors with high levels of this protein were more aggressive.

Methodology

The study used immunohistochemical techniques to evaluate c-erbB3 expression in breast cancer tissues.

Limitations

The study did not include a follow-up on patient outcomes or a larger sample size for more definitive conclusions.

Participant Demographics

Patients included 66 diagnosed under 50 years and 38 diagnosed at 50 years or older.

Statistical Information

P-Value

0.004

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication